Icon

EZALLOR SPRINKLE (nda208647)- (EQ 5MG BASE,EQ 10MG BASE,EQ 20MG BASE,EQ 40MG BASE)

ROSUVASTATIN CALCIUM SUN PHARM
EQ 5MG BASE,EQ 10MG BASE,EQ 20MG BASE,EQ 40MG BASE
No Yes
2036-Feb-12 Expired
None None
None No
EZALLOR Sprinkle is an HMG Co-A reductase inhibitor indicated for: • adult patients with hypertriglyceridemia as an adjunct to diet • adult patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet • adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 5MG BASE ** ** - - -
EQ 10MG BASE ** ** - - -
EQ 20MG BASE ** ** - - -
EQ 40MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.